Capricor Therapeutics CAPR Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | $0— | $0— | $0— | $0-100% | ||
| $27.38M+18.3% | $23.13M+13.6% | $20.36M-7.7% | $22.05M+16.6% | $18.92M+30.0% | ||
| $9.4M+56.0% | $6.02M+1.7% | $5.92M+4.5% | $5.67M-6.5% | $6.07M+42.0% | ||
| $36.77M+26.1% | $29.16M+10.9% | $26.28M-5.2% | $27.72M+11.0% | $24.98M+32.7% | ||
| -$36.77M-26.1% | -$29.16M-10.9% | -$26.28M+5.2% | -$27.72M-11.0% | -$24.98M-225% | ||
| $2.83M— | —— | $1.71M-5.3% | $1.81M+206% | $591.35K+1.7% | ||
| -$33.94M— | —— | —— | —— | -$24.39M-141% | ||
| $0— | —— | —— | —— | $0-100% | ||
| -$33.94M-12.5% | -$30.17M-22.8% | -$24.57M+5.2% | -$25.91M-6.2% | -$24.39M-243% | ||
| -$0.59+4.8% | -$0.62-14.8% | -$0.54+5.3% | -$0.57-7.5% | -$0.53-382% | ||
| -$36.24M-26.5% | -$28.65M-11.1% | -$25.79M+5.3% | -$27.23M-10.8% | -$24.58M-236% | ||
| -$36.77M-26.1% | -$29.16M-10.9% | -$26.28M+5.2% | -$27.72M-11.0% | -$24.98M-225% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Capricor Therapeutics's income statement data come from?
- Every line is extracted from Capricor Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.